U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H31F6N7O2
Molecular Weight 635.6033
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SLV-317 FREE BASE

SMILES

FC(F)(F)C1=CC(=CC(=C1)C(=O)N2CCN(CC3=NNN=C3CN4CCOCC4)C[C@H]2CC5=CNC6=C5C=CC=C6)C(F)(F)F

InChI

InChIKey=SXASYKWUZQHLET-HSZRJFAPSA-N
InChI=1S/C30H31F6N7O2/c31-29(32,33)21-11-19(12-22(14-21)30(34,35)36)28(44)43-6-5-42(16-23(43)13-20-15-37-25-4-2-1-3-24(20)25)18-27-26(38-40-39-27)17-41-7-9-45-10-8-41/h1-4,11-12,14-15,23,37H,5-10,13,16-18H2,(H,38,39,40)/t23-/m1/s1

HIDE SMILES / InChI

Molecular Formula C30H31F6N7O2
Molecular Weight 635.6033
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Severe embryopathy and exposure to methimazole in early pregnancy.
2002-02
Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution.
2002-02
Influence of hypothyroidism on circulating concentrations and liver expression of IGF-binding proteins mRNA from neonatal and adult rats.
2002-02
Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment.
2002-02
Streptozotocin diabetes protects against arrhythmias in rat isolated hearts: role of hypothyroidism.
2002-01-25
Polarization IR spectra of model crystals containing cyclic N-H...S bonded dimers: 2-mercaptothiazoline and 2-mercapto-1-methylimidazole.
2002-01-15
Subclinical hyperthyroidism.
2002-01-03
Depigmentation of brown Guinea pig skin by topical application of methimazole.
2002-01
Severe and mild neonatal hypothyroidism mediate opposite effects on Leydig cells of rats.
2002-01
Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil.
2002-01
Methimazole-induced asthma?
2002-01
Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.
2002-01
Impact of hyperthyroidism and its correction on vascular reactivity in humans.
2001-12-18
Protracted expression of serotonin transporter and altered thalamocortical projections in the barrelfield of hypothyroid rats.
2001-12
Hypothyroidism induces type I iodothyronine deiodinase expression in tilapia liver.
2001-12
Effects of neonatal hypothyroidism on the expressions of growth cone proteins and axon guidance molecules related genes in the hippocampus.
2001-11-26
Apoptosis, necrosis, and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells.
2001-11-15
[Graves-Basedow disease associated with unusual variation of thyroid papillary carcinoma: a clinical case].
2001-11-02
Methimazole-induced pulmonary hemorrhage associated with antimyeloperoxidase-antineutrophil cytoplasmic antibody: a case report.
2001-11
Hyperemesis gravidarum associated with thyrotoxicosis and a past history of an eating disorder.
2001-11
Influence of nicotinamide on the radiosensitivity of normal and goitrous thyroid in the rat.
2001-11
Adverse effects of prenatal methimazole exposure.
2001-11
Effect of eicosapentaenoic acid ethyl ester on hypothyroid function.
2001-11
Methimazole as an antioxidant and immunomodulator in thyroid cells: mechanisms involving interferon-gamma signaling and H(2)O(2) scavenging.
2001-11
Radioiodine and Graves' ophthalmopathy reconsidered.
2001-11
Different role of insulin in GLUT-1 and -4 regulation in heart and skeletal muscle during perinatal hypothyroidism.
2001-11
The effect of methimazole on thyroid uptake of pertechnetate and radioiodine in normal cats.
2001-10-27
Thyroid hormones modify susceptibility to lidocaine-kindling in rats.
2001-10-19
Selective effect of hypothyroidism on expression of myelin markers during development.
2001-10-15
Neonatal hyperthyroidism in infants of mothers previously thyroidectomized due to Graves' disease.
2001-10-11
Dermatomyositis and Graves' disease.
2001-10-03
Severe myocardial ischemia following hormone replacement in two cases of hypothyroidism with normal coronary arteriogram.
2001-10
Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration.
2001-10
Suppression of serum TSH by Graves' Ig: evidence for a functional pituitary TSH receptor.
2001-10
Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism.
2001-10
Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
2001-09
Effect of losartan on sodium appetite of hypothyroid rats subjected to water and sodium depletion and water, sodium and food deprivation.
2001-09
Thyroid hormone regulates oxidative phosphorylation in the cerebral cortex and striatum of neonatal rats.
2001-09
Ca(2+)/nicotinamide adenine dinucleotide phosphate-dependent H(2)O(2) generation is inhibited by iodide in human thyroids.
2001-09
Clinical practice. Subclinical hyperthyroidism.
2001-08-16
[Long-term results of ultrasound-guided ethanol injections in patients with autonomous thyroid nodules and hyperthyroidism].
2001-08-15
Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color duplex sonography.
2001-08
A case of thyrotoxicosis with pancytopenia.
2001-06
[Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
2001-03-10
Sequencing, expression, and characterization of cDNA expressed flavin-containing monooxygenase 2 from mouse.
2001
Body, heart, thyroid gland and skeletal muscle weight changes in rats with altered thyroid status.
2001
Drug-induced congenital defects: strategies to reduce the incidence.
2001
Role of thyroid hormones in the maturation and organisation of rat barrel cortex.
2001
[Ablative therapy for immune hyperthyroidism in patients with ophthalmopathy].
2001
The activity of antioxidant enzymes and the content of uncoupling protein-1 in the brown adipose tissue of hypothyroid rats: comparison with effects of iopanoic acid.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:36:18 GMT 2025
Edited
by admin
on Mon Mar 31 23:36:18 GMT 2025
Record UNII
WPL66843QN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SLV-317(FREE BASE)
Preferred Name English
SLV-317 FREE BASE
Common Name English
METHANONE, (3,5-BIS(TRIFLUOROMETHYL)PHENYL)((2R)-2-(1H-INDOL-3-YLMETHYL)-4-((5-(4-MORPHOLINYLMETHYL)-2H-1,2,3-TRIAZOL-4-YL)METHYL)-1-PIPERAZINYL)-
Systematic Name English
PIPERAZINE, 1-(3,5-BIS(TRIFLUOROMETHYL)BENZOYL)-2-(1H-INDOL-3-YLMETHYL)-4-((5-(4-MORPHOLINYLMETHYL)-2H-1,2,3-TRIAZOL-4-YL)METHYL)-, (2R)-
Systematic Name English
(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-((2R)-2-(1H-INDOL-3-YLMETHYL)-4-((5-(MORPHOLINOMETHYL)-2H-TRIAZOL-4-YL)METHYL)PIPERAZIN-1-YL)METHANONE
Systematic Name English
Code System Code Type Description
MANUFACTURER PRODUCT INFORMATION
(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-((2R)-2-(1H-INDOL-3-YLMETHYL)-4-((5-(MORPHOLINOMETHYL)-2H-TRIAZOL-4-YL)METHYL)PIPERAZIN-1-YL)METHANONE
Created by admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
PRIMARY
PUBCHEM
11635932
Created by admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
PRIMARY
FDA UNII
WPL66843QN
Created by admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
PRIMARY
CAS
393101-98-9
Created by admin on Mon Mar 31 23:36:18 GMT 2025 , Edited by admin on Mon Mar 31 23:36:18 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY